CanDapi Develops and produces an innovative patented Single-Dose Dry Powder Inhaler based on VibraMesh™ Technology. CanDapi's platform can deliver medications, including cannabinoids to the lungs in the form of a dry powder for various treatments.
- Tested technology –highest scores on absorption vs. Competitors (>90% efficiency)
- Simple and easy to use DPI – the most important feature of an ideal inhaler during an attack.
- Suits everyone – Multi-age and disabled patients, from babies to the elderly.
- Precise dosing – accurate DPI of 1-25mg drug delivery
- Customizable
- Suitable for any patient
- Delivery of soluble medical cannabinoid powder, while smoking or vaping are harmful to patients.
- Low cost – low-cost production and a low price for the end customer.
- Very long shelf life – not affected for a long periods by moisture, static electricity and or contaminations.
- Not affected by exhalation.
- No need for operating instructions – avoids the need for warnings or special user instructions.
VibraMesh™ CanDapi DPI is an inhaler in which the user can inhale according to his ability, can blow into it, can breathe through it, can turn it over- the patient will receive the required drug powder with an efficiency no less than 90% at any age and in any health and medical condition.
In addition, CanDapi develops a new line of delivery platforms to the lungs and nose for capsuled drugs in powder or liquid forms